Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers December 18, 2018
Pharmacy Choice - News - Drug Delivery Systems - December 18, 2018

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 100     Next >>     Go To Page:

12/17/18 - Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis
DUBLIN and CAMBRIDGE, Mass., Dec. 17, 2018/ PRNewswire/ Alkermes plc and Biogen Inc. today announced that Alkermes has submitted a New Drug Application to the U.S. Food and Drug Administration for diroximel fumarate, a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis. Alkermes is seeking approval of di
12/17/18 - Cipher Pharmaceuticals Announces PLECANATIDE Accepted for Review by Health Canada
-Cipher Pharmaceuticals Inc. today announced that its New Drug Submission for plecanatide for irritable bowel syndrome with constipation has been accepted by Health Canada. Cipher acquired the Canadian rights to develop, market, distribute and sell plecanatide from Synergy Pharmaceuticals Inc. in February 2018. TRULANCE is a once-daily tablet...
12/17/18 - FDA approves Shire's Motegrity(TM) (prucalopride), the only serotonin-4 receptor agonist for adults with Chronic Idiopathic Constipation (CIC)
Cambridge, Mass. Shire plc has announced that the U.S. Food and Drug Administration has approved Motegrity (TM), a once-daily, oral treatment option for adults with Chronic Idiopathic Constipation. 1. Motegrity, a selective serotonin-4 receptor agonist, provides a different class of treatment for CIC that works by enhancing colonic peristalsis to
12/17/18 - FDA approves Shire's Motegrity? (prucalopride), the only serotonin-4 receptor agonist for adults with Chronic Idiopathic Constipation (CIC)
Cambridge, Mass. December 17, 2018 Shire plc has announced that the U.S. Food and Drug Administration has approved Motegrity?, a once-daily, oral treatment option for adults with Chronic Idiopathic Constipation. 1. Motegrity, a selective serotonin-4 receptor agonist, provides a different class of treatment for CIC that works by enhancing co
12/17/18 - Global Drug Delivery Technologies Market Analysis & Trends - Industry Forecast to 2027 - ResearchAndMarkets.com
The "Global Drug Delivery Technologies Market Analysis& Trends- Industry Forecast to 2027" report has been added to ResearchAndMarkets.com' s offering. The Global Drug Delivery Technology Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include growing demand for bio
12/17/18 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 61642) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee to discuss new drug application 210934 for sotagliflozin oral tablet, sponsored by Sanofi-Aventis U.S. LLC, for the proposed indication: Adjunct to insulin therapy to improve glycemic control in adul
12/17/18 - INSYS Therapeutics Provides Update on Strategic Alterative Review Process and Product Pipeline Spanning Pharmaceutical Cannabinoids and Spray Technology
INSYS Therapeutics, Inc., a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today provided an update on its product pipeline, which includes cannabidiol oral solution as well as epinephrine and naloxone nasal sprays.. Our strategic shift in focus away from opioids and to...
12/17/18 - IV Therapy and Vein Access Devices Market- Dynamics, Segments and Supply Demand 2019
Albany, NY 12/17/2018 The global market for intravenous and vein access devices encompasses a variety of devices such as peripheral venous access, central venous access, ambulatory infusion, enteral feeding, syringe infusion, implantable pumps and diabetes insulin infusion devices. Some of the commercially available products are Patrol Entera
12/17/18 - Launch of Generic Lialda Delayed-Release Tablets Expands Mylan's Gastroenterology Product Offering
HERTFORDSHIRE, England and PITTSBURGH, Dec. 17, 2018/ PRNewswire/ Global pharmaceutical company Mylan N.V. today announced the U.S. launch of Mesalamine Delayed-Release Tablets USP, 1.2 g, a generic version of Shire's Lialda Delayed-Release Tablets. Mylan Pharmaceuticals received final approval from the U.S. Food and Drug Administration for it
12/17/18 - New ingestible capsule with bluetooth can monitor health [New Indian Express (India)]
BOSTON: Scientists have developed an ingestible, capsule controlled using Bluetooth wireless technology, which can be customised to deliver drugs or monitor health over long periods of time. "Our system could provide closed-loop monitoring and treatment, whereby a signal can help guide the delivery of a drug or tuning the dose of a drug," said Gio
12/17/18 - Notification of a New Drug Application for HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.
Hisamitsu Pharmaceutical Co., Ltd., in conjunction with its U.S. subsidiary, Noven Pharmaceuticals, Inc., announces that a New Drug Application has been submitted to the U.S. Food and Drug Administration seeking approval of HP-3070 transdermal system for the treatment of schizophrenia. Hisamitsu Pharmaceutical expects the investigational product to
12/17/18 - Omeprazole Market to Surpass US$ 4.1 Billion by 2026
Omeprazole Market) was valued at US$ 2,668.4 million in 2017, and is projected to exhibit a CAGR of 5.2% over the forecast period (2018- 2026). Global Omeprazole Market, by Dosage Form (Capsule, Powder, and Tablet), by Indication (Duodenal Ulcer, Gastric Ulcer, Gastroesophageal Reflux Disease, Erosive Esophagitis, and Others), by Distribution Chann
12/17/18 - Takeda Receives Positive CHMP Opinion for ADCETRIS for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
Cambridge- Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion for the extension of the marketing authorization of ADCETRIS and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV..
12/15/18 - Global Needle-Free Drug Delivery Technology Market Insight Growth Oppurtunities on Revenue, Share, Size and Volume in-Depth 2017-2026
New York, NY 12/15/2018 A report on Needle-Free Drug Delivery Technology begins with a deep introduction of the global Needle-Free Drug Delivery Technology market and then delves broad into specific segments such as technology application, end user and region, policy study, Needle-Free Drug Delivery Technology value chain structure, and upcom
12/15/18 - Hebei Medical University Fourth Hospital Ct Double Cylinder High Pressure Syringe and Other Medical Equipment Procurement Project (International Bidding)
Company: FOURTH HOSPITAL OF HEBEI MEDICAL UNIVERSITY. 12 Health Road, Shijiazhuang City, Attn: Luolei, Tel: +86-311-86095626. Description: Project Name: Hebei Medical University fourth hospital CT double cylinder high pressure syringe and other medical equipment procurement project Tenders are invited for A Batch of Purchasing Items of Ct Double Ba
12/15/18 - Injectable Drug Delivery Market: In-Depth Evaluation on Growth, Share, Size and Trends Until the End of 20182028: Drug delivery refers to the approaches, technologies and systems used for the administration of drugs to patients.
Albany, NY 12/15/2018 In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine has included a new report titled " Injectable Drug Delivery Market" to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to tr
12/15/18 - Rotigotine 2mg / 24hr Transdermal Patch
Company: KING ABDULAZIZ MEDICAL CITY- RIYADH. Address: Health Affairs, Ministry of National Guard, Purchasing Department, King Abdulaziz Medical City, Riyadh Phone: +966-11-8011111 Fax: +966-11-8011000 P.O. Description: Tenders are invited for Insurance and Supply of Medicines Hz-1372423-Rotigotine 2 mg/ 24 hr Transdermal Patch Tender Type: Invitat
12/14/18 - Blow Fill Seal Equipment Market Is Appraised to Be Valued US$ 7,692.9 Mn by 2028: Blow fill seal Equipment Market is Anticipated to Register at a Healthy CAGR of 5.9% During the Forecast Period 2018 2028
Valley Cottage, NY 12/14/2018 Increasing demand for aseptic packaging in the pharmaceutical industry is projected to be a critical factor driving the sales of blow-fill-seal equipment required for packaging forms including vials, bottles, prefilled syringes, and ampoules. Moreover, unique ability of blow-fill-seal equipment to pack formula
12/14/18 - LUPIN GETS US NOD FOR MULTIPLE SCLEROSIS DRUG
Pharmaceutical firm Lupin Limited has got a tentative approval from the United States Food and Drug Administration to market Dimethyl Fumarate delayed release capsules. The company received the tentative approval from the US health regulator for generic version of Biogen Inc's Tecfidera capsules of strengths 120 milligram and 240 mg.
12/14/18 - Mayne Pharma receives FDA approval of Tolsura (SUBA-itraconazole capsules) for the treatment of certain fungal infections [T-break Tech (Middle East)]
Mayne Pharma Group Limited is pleased to announce that the US Food and Drug Administration has approved the New Drug Application for Tolsura 65 mg capsules. Mayne Pharma`s CEO, Mr Scott Richards said, "We are very pleased to have received FDA approval of this patented formulation of itraconazole which incorporates Mayne Pharma`s proprietary SUBA te
12/14/18 - Nicotine 21mg / 24hr Transdermal Patch
Company: KING FAHAD HOSPITAL JEDDAH. Address: Medical Services Armed Forces- King Fahd Hospital Jeddah- Direct Purchase P. O. Box 9862, Jeddah, 21159 TEL: 2328888 FAX:+ 9 663- 8936. Description: Tenders are invited for Nicotine 21 mg/ 24 hr Transdermal Patch 003 Tender Type: Invitations/ Direct Purchase Purpose of Tender: Providing medicines to the
12/14/18 - ORAMED PHARMACEUTICALS INC. FILES (8-K) Disclosing Other Events
As previously disclosed, pursuant to a Patent Transfer Agreement dated February 22, 2011, Oramed Ltd., a wholly owned subsidiary of Oramed Pharmaceuticals Inc., assigned to Entera Bio Ltd. all of its right, title and interest in and to a certain patent application related to the oral administration of proteins. Under the Patent Transfer Agreement,
12/14/18 - Prefilled Syringes Drug Molecules Market Growing at a CAGR of 5.7% During the Forecast Period 2017-2027: Low reliance on health care professionals and surge in demand for self-administrated devices may boost the global prefilled syringes drug molecul
Valley Cottage, NY 12/14/2018 Global Prefilled Syringes Drug Molecules Market: Snapshot. Prefilled syringes drug molecules are prefilled with medication by the manufactures and are supplied to end users in the ready-to-use form. According to the market analysis, the global prefilled syringes drug molecules market is expected to reach a market
12/14/18 - Takeda Receives Positive CHMP Opinion for ADCETRIS (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
If Authorized in Europe, ADCETRIS in Combination with AVD Will Be the First New Treatment Regimen Available for Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Decades. CAMBRIDGE, Mass.& OSAKA, Japan Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency s Committee for Medi
12/13/18 - Advanced Parenteral Drug Delivery Devices Market Poised to Garner Maximum Revenues by 2025
Albany, NY 12/13/2018 Parenteral drug delivery devices are used for administration of drugs by routes other than the oral mode of dosage. Technological advancement in the area of parenteral drug delivery systems has led to development of innovative devices that enable sophisticated mode of drug targeting and controlled release of parenteral m
Articles(s): 1 - 25 of 100     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415